Why Moelis Australia Ltd is a favourite of this top fund manager

Moelis Australia Ltd (ASX:MOE) has been a good performer for NAOS Absolute Opportunities Co Ltd (ASX:NAC).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of my favourite ways to discover new 'hot' shares is to scour high-performing managers' portfolios to see what they hold (or held) and therefore what they think could be an opportunity.

Some listed investment companies (LICs) release monthly reports about their performance and holdings. One of those high-performing LICs is NAOS Absolute Opportunities Co Ltd (ASX: NAC), its portfolio has returned an average of 20.54% per year over the past three years.

One of the largest contributions to that performance has been Moelis Australia Ltd (ASX: MOE). Moelis is a financial services group that operates three divisions. Its three segments are corporate advisory, equities and asset management.

Since its establishment in 2009 Moelis Australia has advised on corporation transactions worth over $75 billion, raised more than $6.1 billion in capital for clients and manages assets worth more than $2.8 billion.

One of its best deals was buying the Redcape Hotel Group for $677 million last year and raising more capital to grow the business.

Moelis' share price has more than doubled over the past year and there could be plenty more growth to come. It recently upgraded its full-year earnings before interest, tax, depreciation and amortisation (EBITDA) by 15% to at least $38 million on underlying revenue that is expected to exceed $100 million.

I like Moelis' way of doing things and it's not afraid to go for a long-term, unpopular choice. For example, it recently took almost a 10% stake in Japara Healthcare Ltd (ASX: JHC). This should provide the business with good dividend income and perhaps good long-term growth as well.

Foolish takeaway

Moelis might not be to some investors' liking, but I think it could be a market-beater because of the deals it can create that simply aren't available to most other investment businesses.

Motley Fool contributor Tristan Harrison owns shares of JAPARA DEF SET. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »